financetom
Business
financetom
/
Business
/
Rupa & Co accepts resignation of CEO Dinesh Kumar Lodha and CFO Ramesh Agarwal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rupa & Co accepts resignation of CEO Dinesh Kumar Lodha and CFO Ramesh Agarwal
May 23, 2022 1:43 PM

Rupa & Co on Monday announced that accepted the resignation of Chief Executive Officer (CEO) Dinesh Kumar Lodha and Chief Financial Officer (CFO) Ramesh Agarwal.

Share Market Live

NSE

Both resignations will be in effect from May 31.

In an exchange filing, the company stated that Agarwal will continue to hold the Whole Time Director position at the firm.

He would be replaced by Sumit Khowala as the CFO with effect from June 1.

Rupa & Co Ltd's board of directors met on Monday to approve the resignations of Agarwal and Lodha and also to appoint the company's Additional Director (Non-Executive Independent), which was secured by Sunil Rewachand Chnadiramani.

Also Read:

WhiteHat Jr saw fewer than 250 resignations & not 800 when employees were asked to return to office

Vikash Agarwal was appointed as the company's Additional Director (Whole-time category) for five years, with effect from Monday, based on the recommendation of the Nomination and Remuneration Committee. His appointment is subject to the company members' approval in the ensuing Annual General Meeting.

Rupa & Co also re-appointed Niraj Kabra as the Company's executive director for a period of five years. His appointment will be in effect from February 23, next year, subject to the company members' approval in the ensuing Annual General Meeting.

Rupa & Co said that Agarwal, Kabra and Chandiramani, will not be debarred from holding director's office by virtue of any order of the SEBI or any such authority.

Also Read: Top-level exits continue at Ola as vehicle sales platform CEO Arun Sirdeshmukh quits now

First Published:May 23, 2022 10:43 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Nov 3, 2024
07:11 AM EDT, 10/31/2024 (MT Newswires) -- Entergy ( ETR ) reported Q3 adjusted earnings Thursday of $2.99 per share, down from $3.27 a year earlier. Analysts polled by Capital IQ expected $2.99. The company said it now expects fiscal 2024 adjusted EPS of $7.15 to $7.35. That compares with its previous forecast of $7.05 to $7.35. Analysts polled by...
Xcel Energy's Q3 Earnings Rise, Revenue Falls
Xcel Energy's Q3 Earnings Rise, Revenue Falls
Nov 3, 2024
07:04 AM EDT, 10/31/2024 (MT Newswires) -- Xcel Energy ( XEL ) reported Q3 ongoing earnings Thursday of $1.25 per diluted share, up from $1.23 a year earlier. Analysts polled by Capital IQ expected $1.26 normalized. Revenue for the quarter ended Sept. 30 was $3.64 billion compared with $3.66 billion a year earlier. Analysts surveyed by Capital IQ expected $3.93...
Comcast tops revenue expectations on Olympics ad boost, blockbuster releases
Comcast tops revenue expectations on Olympics ad boost, blockbuster releases
Nov 3, 2024
(Reuters) -Comcast ( CMCSA ) beat third-quarter revenue estimates on Thursday, driven by strong box office performance for its studio, higher ad sales during the 2024 Paris Olympics and a smaller-than-expected decline in broadband subscribers. Shares of the company rose 4.2% in premarket trading. The company's media business saw a $1.9 billion revenue boost from the Paris Games, its highest-ever...
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
Nov 3, 2024
Oct 31 (Reuters) - Aerovate Therapeutics Inc ( AVTE ): * AEROVATE THERAPEUTICS AND JADE BIOSCIENCES ANNOUNCE MERGER AGREEMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - JADE SECURES $300 MILLION IN PRIVATE INVESTMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - STOCKHOLDERS TO OWN 1.6% OF COMBINED COMPANY * AEROVATE THERAPEUTICS INC ( AVTE ) - TOM FROHLICH TO...
Copyright 2023-2026 - www.financetom.com All Rights Reserved